{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:45:31Z","timestamp":1787874331322,"version":"build-2784847793"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Grants-in-Aid KAKENHI","award":["21K1643"],"award-info":[{"award-number":["21K1643"]}]},{"name":"Public Trust Surgery Research Fund"},{"name":"Kyoto Healthcare Society Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The role of the ferroptosis-related gene glutathione peroxidase 4 (GPX4) in oncology has been extensively investigated. However, the clinical implications of GPX4 in patients with intrahepatic cholangiocarcinoma (ICC) remain unknown. This study aimed to evaluate the prognostic impact of GPX4 and its underlying molecular mechanisms in patients with ICC. Fifty-seven patients who underwent surgical resection for ICC between 2010 and 2017 were retrospectively analyzed. Based on the immunohistochemistry, patients were divided into GPX4 high (n\u2005=\u200515) and low (n\u2005=\u200542) groups, and clinical outcomes were assessed. Furthermore, the roles of GPX4 in cell proliferation, migration and gene expression were analyzed in ICC cell lines in vitro and in vivo. The results from clinical study showed that GPX4 high group showed significant associations with high SUVmax on 18F-fluorodeoxyglucose-positron emission tomography (\u22658.0, P\u2005=\u20050.017), multiple tumors (P\u2005=\u20050.004), and showed glucose transporter 1 (GLUT1) high expression with a trend toward significance (P\u2005=\u20050.053). Overall and recurrence-free survival in the GPX4 high expression group were significantly worse than those in the GPX4 low expression group (P\u2005=\u20050.038 and P\u2005&amp;lt;\u20050.001, respectively). In the experimental study, inhibition of GPX4 attenuated cell proliferation and migration in ICC cell lines. Inhibition of GPX4 also decreased the expression of glucose metabolism-related genes, such as GLUT1 or HIF1\u03b1. Mechanistically, these molecular changes are regulated in Akt\u2013mechanistic targets of rapamycin axis. In conclusion, this study suggested the pivotal value of GPX4 serving as a prognostic marker for patients with ICC. Furthermore, GPX4 can mediate glucose metabolism of ICC.<\/jats:p>","DOI":"10.1093\/carcin\/bgad094","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T02:16:50Z","timestamp":1703125010000},"page":"119-130","source":"Crossref","is-referenced-by-count":7,"title":["Ferroptosis-related gene glutathione peroxidase 4 promotes reprogramming of glucose metabolism via Akt\u2013mTOR axis in intrahepatic cholangiocarcinoma"],"prefix":"10.1093","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7410-5831","authenticated-orcid":false,"given":"Yutaro","family":"Hori","sequence":"first","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine, Kyoto University , Kyoto , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Yoh","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine, Kyoto University , Kyoto , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Nishino","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine, Kyoto University , Kyoto , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Okura","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine, Kyoto University , Kyoto , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kurimoto","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine, Kyoto University , Kyoto , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Takamatsu","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine, Kyoto University , Kyoto , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiko","family":"Satoh","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine, Kyoto University , Kyoto , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Nishio","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine, Kyoto University , Kyoto , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Koyama","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine, Kyoto University , Kyoto , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamichi","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine, Kyoto University , Kyoto , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Iwaisako","sequence":"additional","affiliation":[{"name":"Department of Medical Life Systems, Faculty of Life and Medical Science, Doshisha University , Kyotanabe , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Surgery, Faculty of Medicine, Kochi Medical School , Nankoku , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuro","family":"Hatano","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine, Kyoto University , Kyoto , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,12,20]]},"reference":[{"key":"2024031109165469100_CIT0001","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/ijc.32760","article-title":"Abdominal and gluteofemoral size and risk of liver cancer: the liver cancer pooling project","volume":"147","author":"Florio","year":"2020","journal-title":"Int. J. Cancer"},{"key":"2024031109165469100_CIT0002","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"key":"2024031109165469100_CIT0003","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s00268-019-04966-4","article-title":"Trends in the incidence, treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the USA: facility type is associated with margin status, use of lymphadenectomy and overall survival","volume":"43","author":"Wu","year":"2019","journal-title":"World J. Surg."},{"key":"2024031109165469100_CIT0004","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000449339","article-title":"Is surgical resection justified for advanced intrahepatic cholangiocarcinoma","volume":"5","author":"Yoh","year":"2016","journal-title":"Liver Cancer"},{"key":"2024031109165469100_CIT0005","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol."},{"key":"2024031109165469100_CIT0006","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(22)02038-4","article-title":"Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial","volume":"401","author":"Nakachi","year":"2023","journal-title":"Lancet"},{"key":"2024031109165469100_CIT0007","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"2024031109165469100_CIT0008","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"2024031109165469100_CIT0009","article-title":"Ferroptosis: past, present and future","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"2024031109165469100_CIT0010","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s10120-021-01159-8","article-title":"Apatinib induced ferroptosis by lipid peroxidation in gastric cancer","volume":"24","author":"Zhao","year":"2021","journal-title":"Gastric Cancer"},{"key":"2024031109165469100_CIT0011","article-title":"mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"2024031109165469100_CIT0012","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.freeradbiomed.2021.04.024","article-title":"H-ferritin suppression and pronounced mitochondrial respiration make hepatocellular carcinoma cells sensitive to RSL3-induced ferroptosis","volume":"169","author":"Asperti","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"2024031109165469100_CIT0013","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00268-019-04917-z","article-title":"Reappraisal of prognostic impact of tumor SUVmax by 18F-FDG-PET\/CT in intrahepatic cholangiocarcinoma","volume":"43","author":"Yoh","year":"2019","journal-title":"World J. Surg."},{"key":"2024031109165469100_CIT0014","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1245\/s10434-017-6025-x","article-title":"8th Edition of the AJCC Cancer Staging Manual: pancreas and hepatobiliary cancers","volume":"25","author":"Chun","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"2024031109165469100_CIT0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann. Surg."},{"key":"2024031109165469100_CIT0016","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1007\/s00268-016-3583-1","article-title":"Significant improvement in outcomes of patients with intrahepatic cholangiocarcinoma after surgery","volume":"40","author":"Yoh","year":"2016","journal-title":"World J. Surg."},{"key":"2024031109165469100_CIT0017","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1245\/s10434-016-5708-z","article-title":"A novel biomarker-based preoperative prognostic grading system for predicting survival after surgery for intrahepatic cholangiocarcinoma","volume":"24","author":"Yoh","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"2024031109165469100_CIT0018","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O","article-title":"Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments","volume":"19","author":"Mazumdar","year":"2000","journal-title":"Stat. Med."},{"key":"2024031109165469100_CIT0019","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/cncr.29686","article-title":"Proposal of a new staging system for intrahepatic cholangiocarcinoma: analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan","volume":"122","author":"Sakamoto","year":"2016","journal-title":"Cancer"},{"key":"2024031109165469100_CIT0020","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrc2468","article-title":"Hypoxia, HIF1 and glucose metabolism in the solid tumour","volume":"8","author":"Denko","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"2024031109165469100_CIT0021","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.radonc.2015.08.025","article-title":"The association of (18)F-FDG PET and glucose metabolism biomarkers GLUT1 and HK2 in p16 positive and negative head and neck squamous cell carcinomas","volume":"117","author":"Baschnagel","year":"2015","journal-title":"Radiother. Oncol."},{"key":"2024031109165469100_CIT0022","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF02623562","article-title":"A new human cholangiocellular carcinoma cell line (HuCCT-1) producing carbohydrate antigen19\/9 in serum-free medium in serum-free medium","volume":"25","author":"Miyagiwa","year":"1989","journal-title":"In Vitro Cell. Dev. Biol."},{"key":"2024031109165469100_CIT0023","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/hep.510260206","article-title":"Hepatocytic phenotypes induced in sarcomatous cholangiocarcinoma cells treated with 5-azacytidine","volume":"26","author":"Enjoji","year":"1997","journal-title":"Hepatology"},{"key":"2024031109165469100_CIT0024","doi-asserted-by":"crossref","first-page":"63779","DOI":"10.18632\/oncotarget.11687","article-title":"RSL3 and erastin differentially regulate redox signaling to promote Smac mimetic-induced cell death","volume":"7","author":"D\u00e4chert","year":"2016","journal-title":"Oncotarget"},{"key":"2024031109165469100_CIT0025","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/8929525","article-title":"miR-21-5p inhibits ferroptosis in hepatocellular carcinoma cells by regulating the AKT\/mTOR signaling pathway through MELK","author":"Hu","year":"2023","journal-title":"J. Immunol. Res."},{"key":"2024031109165469100_CIT0026","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41417-020-0182-y","article-title":"Interplay between MTOR and GPX4 signaling modulates autophagy-dependent ferroptotic cancer cell death","volume":"28","author":"Liu","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"2024031109165469100_CIT0027","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-23906-2","article-title":"Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer","author":"Sekhar","year":"2022","journal-title":"Sci. Rep."},{"key":"2024031109165469100_CIT0028","doi-asserted-by":"crossref","DOI":"10.1080\/23723556.2021.1919006","article-title":"A mTORC1-mediated cyst(e)ine sensing mechanism governing GPX4 synthesis and ferroptosis","author":"Yan","year":"2021","journal-title":"Mol. Cell. Oncol."},{"key":"2024031109165469100_CIT0029","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1158\/1078-0432.CCR-21-3208","article-title":"PET-based radiogenomics supports mTOR pathway targeting for hepatocellular carcinoma","volume":"28","author":"An","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"2024031109165469100_CIT0030","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1111\/jcmm.17303","article-title":"Effect of Glut-1 and HIF-1\u03b1 double knockout by CRISPR\/CAS9 on radiosensitivity in laryngeal carcinoma via the PI3K\/Akt\/mTOR pathway","volume":"26","author":"Bao","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"2024031109165469100_CIT0031","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3892\/or.2021.8204","article-title":"Berberine exerts its antineoplastic effects by reversing the Warburg effect via downregulation of the Akt\/mTOR\/GLUT1 signaling pathway","volume":"46","author":"Guo","year":"2021","journal-title":"Oncol. Rep."},{"key":"2024031109165469100_CIT0032","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ags3.12367","article-title":"S6 ribosomal protein phosphorylation is associated with malignancy of intraductal papillary mucinous neoplasm of the pancreas","volume":"4","author":"Hirashita","year":"2020","journal-title":"Ann. Gastroenterol. Surg."},{"key":"2024031109165469100_CIT0033","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1158\/0008-5472.CAN-09-1751","article-title":"AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity","volume":"70","author":"Chresta","year":"2010","journal-title":"Cancer Res."},{"key":"2024031109165469100_CIT0034","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"2024031109165469100_CIT0035","first-page":"453","article-title":"Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release","volume":"39","author":"Goetze","year":"2011","journal-title":"Int. J. Oncol."},{"key":"2024031109165469100_CIT0036","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/s41388-017-0070-6","article-title":"Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma","volume":"37","author":"Liu","year":"2018","journal-title":"Oncogene"},{"key":"2024031109165469100_CIT0037","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"2024031109165469100_CIT0038","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canlet.2016.07.035","article-title":"Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer","volume":"381","author":"Roh","year":"2016","journal-title":"Cancer Lett."},{"key":"2024031109165469100_CIT0039","doi-asserted-by":"crossref","first-page":"517","DOI":"10.18632\/oncoscience.160","article-title":"Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells","volume":"2","author":"Eling","year":"2015","journal-title":"Oncoscience"},{"key":"2024031109165469100_CIT0040","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.canlet.2013.12.028","article-title":"New biological perspectives for the improvement of the efficacy of sorafenib in hepatocellular carcinoma","volume":"346","author":"Galmiche","year":"2014","journal-title":"Cancer Lett."},{"key":"2024031109165469100_CIT0041","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.canlet.2014.11.014","article-title":"The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells","volume":"356","author":"Louandre","year":"2015","journal-title":"Cancer Lett."},{"key":"2024031109165469100_CIT0042","doi-asserted-by":"crossref","first-page":"11756","DOI":"10.18632\/oncotarget.7598","article-title":"Functional interactions of the cystine\/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells","volume":"7","author":"Hasegawa","year":"2016","journal-title":"Oncotarget"},{"key":"2024031109165469100_CIT0043","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.104360","article-title":"SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase","author":"Xu","year":"2023","journal-title":"Cell Death Dis."},{"key":"2024031109165469100_CIT0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118782","article-title":"Dual GSH-exhausting sorafenib loaded manganese-silica nanodrugs for inducing the ferroptosis of hepatocellular carcinoma cells","author":"Tang","year":"2019","journal-title":"Int. J. Pharm."},{"key":"2024031109165469100_CIT0045","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1111\/cas.15378","article-title":"Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor-4 inhibition in hepatocellular carcinoma","volume":"113","author":"Iseda","year":"2022","journal-title":"Cancer Sci."}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/carcin\/advance-article-pdf\/doi\/10.1093\/carcin\/bgad094\/54961009\/bgad094.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/carcin\/article-pdf\/45\/3\/119\/56877833\/bgad094.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/carcin\/article-pdf\/45\/3\/119\/56877833\/bgad094.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T09:17:36Z","timestamp":1710148656000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article\/45\/3\/119\/7484495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,12,20]]},"published-print":{"date-parts":[[2024,3,11]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgad094","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"value":"0143-3334","type":"print"},{"value":"1460-2180","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3,1]]},"published":{"date-parts":[[2023,12,20]]}}}